Cardiac Tissue Engineering for Replacement Therapy
暂无分享,去创建一个
[1] Da-Zhi Wang,et al. Activation of Cardiac Gene Expression by Myocardin, a Transcriptional Cofactor for Serum Response Factor , 2001, Cell.
[2] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[3] C. Murry,et al. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. , 1999, Circulation.
[4] Thomas Eschenhagen,et al. Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] H. Schäfers,et al. Cardiomyocytes of Noncardiac Origin in Myocardial Biopsies of Human Transplanted Hearts , 2002, Circulation.
[6] R. Weisel,et al. Survival and function of bioengineered cardiac grafts. , 1999, Circulation.
[7] S R Gonda,et al. Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. , 1999, Tissue engineering.
[8] M. Entman,et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.
[9] Frederick J. Schoen,et al. Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves , 2000, Circulation.
[10] C. Long,et al. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. , 1998, Cardiovascular research.
[11] Larry L Hench,et al. Third-Generation Biomedical Materials , 2002, Science.
[12] G. Koh,et al. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. , 1994, Science.
[13] R. Weisel,et al. In vivo survival and function of transplanted rat cardiomyocytes. , 1996, Circulation research.
[14] M. Sefton,et al. Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.
[15] J. Vacanti,et al. Tissue engineering. , 1993, Science.
[16] W. Zimmermann,et al. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.
[17] I. Skerjanc,et al. Nkx2–5 Activity Is Essential for Cardiomyogenesis* , 2001, The Journal of Biological Chemistry.
[18] Andreas Hess,et al. Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats , 2002, Circulation.
[19] F J Schoen,et al. Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.
[20] J. Epstein,et al. Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts , 2002, Circulation.
[21] A M Wobus,et al. Selection of ventricular‐like cardiomyocytes from ES cells in vitro , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] W. Zimmermann,et al. Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.
[23] F J Schoen,et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. , 1999, Biotechnology and bioengineering.
[24] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[25] G. Koh,et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.
[26] R. Weisel,et al. Fetal cell transplantation: a comparison of three cell types. , 1999, The Journal of thoracic and cardiovascular surgery.
[27] Ursula Ravens,et al. Cardiac tissue engineering. , 2002, Transplant immunology.
[28] R J Cohen,et al. Cardiac muscle tissue engineering : toward an in vitro model for electrophysiological studies , 1999 .
[29] L. Kedes,et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. , 2001, Journal of molecular and cellular cardiology.
[30] J Marler,et al. Transplantation of cells in matrices for tissue regeneration. , 1998, Advanced drug delivery reviews.
[31] C. Long,et al. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. , 1991, Cell regulation.
[32] L Gepstein,et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.
[33] A. Hagège,et al. Myoblast transplantation for heart failure , 2001, The Lancet.
[34] A Haverich,et al. In vitro engineering of heart muscle: artificial myocardial tissue. , 2002, The Journal of thoracic and cardiovascular surgery.
[35] David Tweedie,et al. Differentiation of Pluripotent Embryonic Stem Cells Into Cardiomyocytes , 2002, Circulation research.
[36] C. Barclay,et al. The energetics of rat papillary muscles undergoing realistic strain patterns. , 2001, The Journal of experimental biology.
[37] C. M. Agrawal,et al. Technique to control pH in vicinity of biodegrading PLA-PGA implants. , 1997, Journal of biomedical materials research.
[38] Todd C McDevitt,et al. In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. , 2002, Journal of biomedical materials research.
[39] R. Weisel,et al. Construction of a bioengineered cardiac graft. , 2000, The Journal of thoracic and cardiovascular surgery.
[40] G. Wallukat,et al. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. , 1991, Differentiation; research in biological diversity.
[41] A. Mebazaa,et al. The cardiac endothelium: cardioactive mediators. , 1996, Progress in cardiovascular diseases.
[42] J. Lüdemann,et al. Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. , 1996, Circulation.
[43] G. Cossu,et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] Mitsuo Umezu,et al. Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces , 2002, Circulation research.
[45] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[46] Antonios G Mikos,et al. Biomaterials and Scaffolds in Reparative Medicine , 2002, Annals of the New York Academy of Sciences.
[47] K Rakusan,et al. Functional capillary density in normal and transplanted rat hearts. , 1982, Canadian journal of physiology and pharmacology.
[48] Doris A Taylor,et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.
[49] A. Hagège,et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? , 1997, Circulation.
[50] L. Kedes,et al. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? , 1996, Circulation.
[51] H. Blau,et al. The Evolving Concept of a Stem Cell Entity or Function? , 2001, Cell.
[52] D. Bader,et al. Repair and reorganization of minced cardiac muscle in the adult newt (Notophthalmus viridescens) , 1978, Journal of morphology.
[53] R. Zak,et al. Dissociation of adult mammalian heart into single cell suspension: an ultrastructural study. , 1979, Journal of anatomy.
[54] Anderson,et al. Host response to tissue engineered devices. , 1998, Advanced drug delivery reviews.
[55] Thomas Eschenhagen,et al. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] R. Leyh,et al. A novel bioartificial myocardial tissue and its prospective use in cardiac surgery. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[57] W. Zimmermann,et al. 3D engineered heart tissue for replacement therapy , 2002, Basic Research in Cardiology.
[58] A Haverich,et al. Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.
[59] P. Anversa,et al. Chimerism of the transplanted heart. , 2002, The New England journal of medicine.
[60] B. Fleischmann,et al. Cellular Cardiomyoplasty Improves Survival After Myocardial Injury , 2002, Circulation.
[61] J. Saffitz,et al. Evidence for Cardiomyocyte Repopulation by Extracardiac Progenitors in Transplanted Human Hearts , 2002, Circulation research.
[62] Peter W. Laird,et al. Rebuilding a Damaged Heart: Long-Term Survival of Transplanted Neonatal Rat Cardiomyocytes After Myocardial Infarction and Effect on Cardiac Function , 2002, Circulation.
[63] C. Murry,et al. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. , 2002, Journal of molecular and cellular cardiology.
[64] R. Robbins,et al. Heart transplantation: a thirty-year perspective. , 2002, Annual review of medicine.
[65] Larry Kedes,et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. , 2002, Journal of molecular and cellular cardiology.
[66] Axel Haverich,et al. Tissue engineering of small diameter vascular grafts. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[67] R. Weisel,et al. Autologous transplantation of bone marrow cells improves damaged heart function. , 1999, Circulation.
[68] M. Yacoub,et al. Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart. , 2001, The Journal of thoracic and cardiovascular surgery.
[69] J. Weil,et al. Preserved Frank-Starling mechanism in human end stage heart failure. , 1998, Cardiovascular research.
[70] S. Harding,et al. Evidence for protein phosphatase inhibitor‐1 playing an amplifier role in β‐adrenergic signaling in cardiac myocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[71] R Kemler,et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.
[72] G. Koh,et al. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. , 1993, The American journal of physiology.
[73] R. Bodmer,et al. Heart development in Drosophila and vertebrates: conservation of molecular mechanisms. , 1998, Developmental genetics.
[74] G. Koh,et al. Differentiation and long-term survival of C2C12 myoblast grafts in heart. , 1993, The Journal of clinical investigation.
[75] L. Reinlib,et al. Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. , 2000, Circulation.
[76] John Fisher,et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. , 2002, The Journal of heart valve disease.
[77] D. Melton,et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[78] J. Leor,et al. Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.
[79] D. Kreisel,et al. A novel small animal model of left ventricular tissue engineering. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.